|
US20040022787A1
(en)
*
|
2000-07-03 |
2004-02-05 |
Robert Cohen |
Methods for treating an autoimmune disease using a soluble CTLA4 molecule and a DMARD or NSAID
|
|
EP1878440A1
(en)
*
|
2006-07-13 |
2008-01-16 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and compositions for increasing the efficiency of therapeutic antibodies using gamma delta cell activator compounds
|
|
WO2008127298A2
(en)
*
|
2006-10-24 |
2008-10-23 |
Subroto Chatterjee |
Staphylococcal enterotoxin b peptide compositions and methods of use
|
|
US9044459B2
(en)
*
|
2008-12-05 |
2015-06-02 |
Als Therapy Development Institute |
Method for the treatment of neurodegenerative diseases
|
|
EP2367849B1
(en)
*
|
2008-12-05 |
2017-11-01 |
ALS Therapy Development Institute |
Method for the treatment of neurodegenerative diseases
|
|
CN102573500A
(zh)
*
|
2009-08-06 |
2012-07-11 |
纽拉尔图斯制药公司 |
巨噬细胞相关疾病的治疗
|
|
PL3053932T3
(pl)
*
|
2010-02-19 |
2021-03-08 |
Xencor, Inc. |
Nowe immunoadhezyny CTLA4-IG
|
|
KR102220006B1
(ko)
*
|
2011-03-11 |
2021-02-24 |
아시스땅스 퍼블리끄-오삐또 드 빠리 |
자가면역 - 관련 또는 염증성 장애를 치료하기 위한 저용량 ｉｌ２ 의 용도
|
|
EP2734232B1
(en)
*
|
2011-07-19 |
2017-11-01 |
Philogen S.p.A. |
Sequential anti-ctla4 and targeted il-2 therapy
|
|
WO2013041029A1
(en)
*
|
2011-09-23 |
2013-03-28 |
Igenimed Pharmaceuticals Inc. |
Novel soluble ctla4 variants
|
|
US20140044675A1
(en)
*
|
2012-08-10 |
2014-02-13 |
Roche Glycart Ag |
Interleukin-2 fusion proteins and uses thereof
|
|
WO2014206899A1
(en)
*
|
2013-06-25 |
2014-12-31 |
Icm (Institut Du Cerveau Et De La Moelle Épinière) |
Boosting treg cells for treating alzheimer disease and related disorders
|
|
US20170233485A1
(en)
*
|
2014-08-18 |
2017-08-17 |
Biogen Ma Inc. |
Anti-cd40 antibodies and uses thereof
|
|
EP3192805A1
(en)
*
|
2016-01-15 |
2017-07-19 |
Humanitas Mirasole S.p.A. |
Inhibitors of t cell activation or stimulation and uses thereof
|
|
JP7181862B2
(ja)
*
|
2016-10-18 |
2022-12-01 |
リージェンツ オブ ザ ユニバーシティ オブ ミネソタ |
腫瘍浸潤リンパ球および治療の方法
|
|
US11077172B2
(en)
*
|
2016-11-08 |
2021-08-03 |
Delinia, Inc. |
IL-2 variants for the treatment of psoriasis
|
|
CA3103603A1
(en)
*
|
2018-06-13 |
2019-12-19 |
Akron Biotechnology, LLC. |
Method to prepare therapeutically active aldesleukin highly stable in liquid pharmaceutical compositions
|
|
JP2022510377A
(ja)
*
|
2018-12-03 |
2022-01-26 |
デルマタ・セラピューティクス，エルエルシー |
状態の処置のための組成物
|
|
CN113795271A
(zh)
*
|
2019-03-08 |
2021-12-14 |
森德治疗公司 |
与irgd共施用以治疗癌症的低剂量细胞因子
|
|
CN109999179A
(zh)
*
|
2019-05-08 |
2019-07-12 |
山东省分析测试中心 |
低剂量白介素2用于制备治疗阿尔茨海默病药物中的应用
|